Date Filed | Type | Description |
08/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/24/2020 |
4
| WHITNELL JEFFREY A (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/
Txns:
| Granted 516,781 shares
@ $0.0871, valued at
$45k
|
|
02/27/2018 |
4
| WHITNELL JEFFREY A (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/
Txns:
| Granted 161,374 shares
@ $0.1239, valued at
$20k
|
|
02/27/2017 |
4
| WHITNELL JEFFREY A (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/
Txns:
| Granted 88,679 shares
@ $0.2255, valued at
$20k
|
|
02/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/11/2013 |
4
| WHITNELL JEFFREY A (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/
Txns:
| Granted 184,706 shares
@ $0.08, valued at
$14.8k
Granted 184,706 shares
@ $0.08, valued at
$14.8k
|
|
03/21/2012 |
4
| WHITNELL JEFFREY A (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/
Txns:
| Granted 231,633 shares
@ $0.0969, valued at
$22.4k
|
|
03/16/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/23/2011 |
3
| WHITNELL JEFFREY A (Director) has filed a Form 3 on ELITE PHARMACEUTICALS INC /DE/ |
04/21/2009 |
4
| WHITNELL JEFFREY A (Interim CEO/CFO) has filed a Form 4 on AKORN INC |